Voloridge Investment Management
SUPN icon

Voloridge Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Voloridge Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,497
Closed -$741K – 1362
2024
Q4 		$741K Sell
20,497
-116,964
-85% -$4.12M ﹤0.01% 1072
2024
Q3 		$4.29M Sell
137,461
-34,805
-20% -$1.09M 0.02% 813
2024
Q2 		$4.61M Buy
+172,266
New +$4.99M 0.02% 775
2024
Q1 		– Sell
-149,150
Closed -$4.32M – 1348
2023
Q4 		$4.32M Buy
149,150
+46,647
+46% +$1.24M 0.02% 658
2023
Q3 		$2.83M Buy
102,503
+71,744
+233% +$2.18M 0.01% 824
2023
Q2 		$925K Buy
+30,759
New +$1.08M ﹤0.01% 1134
2021
Q4 		– Sell
-63,894
Closed -$1.7M – 1836
2021
Q3 		$1.7M Buy
+63,894
New +$1.71M 0.01% 1100
2021
Q2 		– Sell
-57,283
Closed -$1.5M – 1780
2021
Q1 		$1.5M Sell
57,283
-72,885
-56% -$2.04M 0.01% 908
2020
Q4 		$3.27M Sell
130,168
-19,632
-13% -$423K 0.03% 574
2020
Q3 		$3.12M Buy
149,800
+6,799
+5% +$154K 0.03% 576
2020
Q2 		$3.4M Buy
143,001
+8,662
+6% +$191K 0.04% 458
2020
Q1 		$2.42M Buy
134,339
+63,110
+89% +$1.33M 0.07% 304
2019
Q4 		$1.69M Buy
71,229
+52,341
+277% +$1.27M 0.03% 527
2019
Q3 		$519K Sell
18,888
-14,628
-44% -$433K 0.01% 800
2019
Q2 		$1.11M Buy
33,516
+4,037
+14% +$138K 0.03% 439
2019
Q1 		$1.03M Sell
29,479
-11,363
-28% -$423K 0.03% 462
2018
Q4 		$1.36M Buy
+40,842
New +$1.76M 0.06% 240
2018
Q3 		– Sell
-33,753
Closed -$2.02M – 454
2018
Q2 		$2.02M Buy
+33,753
New +$1.75M 0.05% 273
2017
Q3 		– Sell
-29,412
Closed -$1.27M – 523
2017
Q2 		$1.27M Buy
+29,412
New +$1.05M 0.03% 306

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Voloridge Investment Management's SUPN Position: Q1 2025 in Review

Voloridge Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 20,497 shares — an estimated $741K sold.

Voloridge Investment Management first reported a position in SUPN in Q2 2017 and held it in 19 quarters. The position peaked at $4.61M in Q2 2024. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Voloridge Investment Management reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 20,497 Supernus Pharmaceuticals shares in Q1 2025, an estimated $741K.
  • Voloridge Investment Management first reported a position in Supernus Pharmaceuticals in Q2 2017 and held it in 19 quarters.
  • Voloridge Investment Management's Supernus Pharmaceuticals position peaked at $4.61M in Q2 2024.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.